Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Fostering Healthy Mental, Emotional, and Behavioral Development in Children and Youth": National Academies Report Calling for a Decade of Children and Youth.1 passage
• 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.1 passage
• 20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.1 passage
• 2014 Annual Report of the American Board of Psychiatry and Neurology, Inc.1 passage
• A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.1 passage
• A Brain Model of Disturbed Self-Appraisal in Depression.1 passage
• A Brief Clinical Tool to Estimate Individual Patients' Risk of Depressive Relapse Following Remission: Proof of Concept.1 passage
• A Contagion Model for Within-Family Transmission of Drug Abuse.1 passage
• A Diffusion Tensor Imaging Study in Children With ADHD, Autism Spectrum Disorder, OCD, and Matched Controls: Distinct and Non-Distinct White Matter Disruption and Dimensional Brain-Behavior Relationships.1 passage
• A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.1 passage
• A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants.1 passage
• A Longitudinal Study of Adjustment Disorder After Trauma Exposure.1 passage
• A Longitudinal Study of Resting-State Connectivity and Response to Psychostimulant Treatment in ADHD.1 passage
• A New Perspective on the Pathophysiology of Borderline Personality Disorder: A Model of the Role of Oxytocin.1 passage
• A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study.1 passage
• A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development.1 passage
• A Population-Based Cohort Study Examining the Incidence and Impact of Psychotic Experiences From Childhood to Adulthood, and Prediction of Psychotic Disorder.1 passage
• A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis.1 passage
• A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.1 passage
• A Randomized Controlled Trial of Executive Functioning Training Compared With Perceptual Training for Schizophrenia Spectrum Disorders: Effects on Neurophysiology, Neurocognition, and Functioning.1 passage
• A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis.1 passage
• A Randomized Controlled Trial of Parent-Child Psychotherapy Targeting Emotion Development for Early Childhood Depression.1 passage
• A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.1 passage
• A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder.1 passage
• A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia.1 passage
• A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder.1 passage
• A Reckoning and Research Agenda for Neuroimaging in Psychiatry.1 passage
• A Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment.1 passage
• A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial.1 passage
• A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial.1 passage
• A Third Linear Association Between Olduvai (DUF1220) Copy Number and Severity of the Classic Symptoms of Inherited Autism.1 passage
• A Twin Study of Normative Personality and DSM-IV Personality Disorder Criterion Counts: Evidence for Separate Genetic Influences.1 passage
• A clinical perspective on the relevance of research domain criteria in electronic health records.1 passage
• A randomized trial of collaborative depression care in obstetrics and gynecology clinics: socioeconomic disadvantage and treatment response.1 passage
• ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.1 passage
• ADHD Medication and Substance-Related Problems.1 passage
• APA Council Reports.2 passages
• Abnormal Sensitization of Neural and Behavioral Responses to Socially Relevant Images in Individuals With Borderline Personality Disorder: Implications for Guiding More Effective Targeting of Treatments.1 passage
• Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study.1 passage
• Accelerated Gray and White Matter Deterioration With Age in Schizophrenia.1 passage
• Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.1 passage
• Addressing Possible Effects of Sleep Apnea in a Study of Methylphenidate for Apathy in Alzheimer's Disease: Response to Kolla and Mansukhani.1 passage
• Adjunctive Antipsychotic Prescriptions for Outpatients with Depressive Disorders in Asia: The Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Study.1 passage
• Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial.1 passage
• Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses.1 passage
• Adolescents Who Self-Harm and Commit Violent Crime: Testing Early-Life Predictors of Dual Harm in a Longitudinal Cohort Study.1 passage
• Adverse Childhood Experiences: Implications for Offspring Telomere Length and Psychopathology.1 passage
• Age Differences in the Neural Correlates of Anxiety Disorders: An fMRI Study of Response to Learned Threat.1 passage
• Age-Associated Deviations of Amygdala Functional Connectivity in Youths With Psychosis Spectrum Disorders: Relevance to Psychotic Symptoms.1 passage
• Alcohol Use Disorder and Risk of Suicide in a Swedish Population-Based Cohort.1 passage
• Alcohol, Tobacco, and Comorbid Psychiatric Disorders and Associations With Sexual Identity and Stress-Related Correlates.1 passage
• All for One and One for All: Mental Disorders in One Dimension.1 passage
• All-Cause Mortality in Women With Severe Postpartum Psychiatric Disorders.1 passage
• Allele-Specific Methylation of SPDEF: A Novel Moderator of Psychosocial Stress and Substance Abuse.1 passage
• Altered Brain Developmental Trajectories in Adolescents After Initiating Drinking.1 passage
• Altered Cellular White Matter But Not Extracellular Free Water on Diffusion MRI in Individuals at Clinical High Risk for Psychosis.1 passage
• Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.1 passage
• Altered Uncinate Fasciculus Microstructure in Childhood Anxiety Disorders in Boys But Not Girls.1 passage
• Amygdala Activity During Autobiographical Memory Recall in Depressed and Vulnerable Individuals: Association With Symptom Severity and Autobiographical Overgenerality.1 passage
• Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia.1 passage
• Amyloid and Tau in Alzheimer's Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger?1 passage
• An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.1 passage
• An Array of Studies Addressing Cognition and Cognitively Defined Neuropsychiatric Conditions: Many More Connections Than You Might Think.1 passage
• An Electroencephalography Connectomic Profile of Posttraumatic Stress Disorder.1 passage
• An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression.1 passage
• An Individualized Risk Calculator for Research in Prodromal Psychosis.1 passage
• Analysis of DNA Methylation in Young People: Limited Evidence for an Association Between Victimization Stress and Epigenetic Variation in Blood.1 passage
• Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity.1 passage
• Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.1 passage
• Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies.1 passage
• Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.1 passage
• As Safe as Possible (ASAP): A Brief App-Supported Inpatient Intervention to Prevent Postdischarge Suicidal Behavior in Hospitalized, Suicidal Adolescents.1 passage
• Association Between ADHD and Obesity: A Systematic Review and Meta-Analysis.1 passage
• Association Between Ambient Air Pollution and Daily Hospital Admissions for Depression in 75 Chinese Cities.1 passage
• Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis.1 passage
• Association Between Insight and Outcome of Psychotherapy: Systematic Review and Meta-Analysis.1 passage
• Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study.1 passage
• Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies.1 passage
• Association Between the Use of Cannabis and Physical Violence in Youths: A Meta-Analytical Investigation.1 passage
• Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma.1 passage
• Association of Cannabis Use-Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001-2002 and 2012-2013.1 passage
• Association of Childhood Maltreatment With Interpersonal Distance and Social Touch Preferences in Adulthood.1 passage
• Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum.1 passage
• Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients.1 passage
• Association of Elevated Reward Prediction Error Response With Weight Gain in Adolescent Anorexia Nervosa.1 passage
• Association of Hormonal Contraception With Suicide Attempts and Suicides.1 passage
• Association of Inflammatory Activity With Larger Neural Responses to Threat and Reward Among Children Living in Poverty.1 passage
• Association of Maternal Insecticide Levels With Autism in Offspring From a National Birth Cohort.1 passage
• Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition.1 passage
• Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders.1 passage
• Association of Prefrontal-Striatal Functional Pathology With Alcohol Abstinence Days at Treatment Initiation and Heavy Drinking After Treatment Initiation.1 passage
• Association of Prenatal Alcohol Exposure With Psychological, Behavioral, and Neurodevelopmental Outcomes in Children From the Adolescent Brain Cognitive Development Study.1 passage
• Association of Prospective Risk for Chronic PTSD Symptoms With Low TNFα and IFNγ Concentrations in the Immediate Aftermath of Trauma Exposure.1 passage
• Association of Protein Phosphatase PPM1G With Alcohol Use Disorder and Brain Activity During Behavioral Control in a Genome-Wide Methylation Analysis.1 passage
• Association of Resting Metabolism in the Fear Neural Network With Extinction Recall Activations and Clinical Measures in Trauma-Exposed Individuals.1 passage
• Association of a History of Child Abuse With Impaired Myelination in the Anterior Cingulate Cortex: Convergent Epigenetic, Transcriptional, and Morphological Evidence.1 passage
• Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study.1 passage
• Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.1 passage
• Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features.1 passage
• Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial.1 passage
• Autism Spectrum Disorder Genetics and the Search for Pathological Mechanisms.1 passage
• Autoimmune Encephalitis in Postpartum Psychosis.1 passage
• Baseline Frontoparietal Task-Related BOLD Activity as a Predictor of Improvement in Clinical Symptoms at 1-Year Follow-Up in Recent-Onset Psychosis.1 passage
• Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment.1 passage
• Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.1 passage
• Bitemporal Versus High-Dose Unilateral Twice-Weekly Electroconvulsive Therapy for Depression (EFFECT-Dep): A Pragmatic, Randomized, Non-Inferiority Trial.1 passage
• Blunted Neural Response to Rewards as a Prospective Predictor of the Development of Depression in Adolescent Girls.1 passage
• Brain Correlates of the Interaction Between 5-HTTLPR and Psychosocial Stress Mediating Attention Deficit Hyperactivity Disorder Severity.1 passage
• Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples.1 passage
• Brain Mechanisms of Attention Orienting Following Frustration: Associations With Irritability and Age in Youths.1 passage
• Brain Reward System Dysfunction in Adolescence: Current, Cumulative, and Developmental Periods of Depression.1 passage
• Brain Structural Abnormalities in a Group of Never-Medicated Patients With Long-Term Schizophrenia.1 passage
• Brain development in heavy-drinking adolescents.1 passage
• Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma.1 passage
• Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up.1 passage
• CBT for Adolescents With Anxiety: Mature Yet Still Developing.1 passage
• CBT for Prolonged Grief in Children and Adolescents: A Randomized Clinical Trial.1 passage
• CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.1 passage
• COMT haplotypes modulate associations of antenatal maternal anxiety and neonatal cortical morphology.1 passage
• COVID-19, Substance Use, Anorexia Nervosa, 22q11.2 Deletion Syndrome, and Stress.1 passage
• Callous-Unemotional Traits and Risk of Gun Carrying and Use During Crime.1 passage
• Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.1 passage
• Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.1 passage
• Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States.1 passage
• Cannabis, Psychosis, and Mortality: A Cohort Study of 50,373 Swedish Men.1 passage
• Care Pathways Before First Diagnosis of a Psychotic Disorder in Adolescents and Young Adults.1 passage
• Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.1 passage
• Cell-Type-Specific Impact of Glucocorticoid Receptor Activation on the Developing Brain: A Cerebral Organoid Study.1 passage
• Cell-Type-Specific Transcriptomic Analysis in the Dorsolateral Prefrontal Cortex Reveals Distinct Mitochondrial Abnormalities in Schizophrenia and Bipolar Disorder.1 passage
• Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia.1 passage
• Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study.1 passage
• Changes to the Diagnostic Criteria for Bipolar Disorder in DSM-5 Make Little Difference to Lifetime Diagnosis: Findings From the U.K. Bipolar Disorder Research Network (BDRN) Study.1 passage
• Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.1 passage
• Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.1 passage
• Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.1 passage
• Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.1 passage
• Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.1 passage
• Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.1 passage
• Cognitive Enhancement Treatment for People With Mental Illness Who Do Not Respond to Supported Employment: A Randomized Controlled Trial.1 passage
• Comment on Analyses and Conclusions of "Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study".1 passage
• Comment on Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.1 passage
• Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study.1 passage
• Common and Dissociable Mechanisms of Executive System Dysfunction Across Psychiatric Disorders in Youth.1 passage
• Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.1 passage
• Complementary Features of Attention Bias Modification Therapy and Cognitive-Behavioral Therapy in Pediatric Anxiety Disorders.1 passage
• Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.1 passage
• Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis.1 passage
• Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms.1 passage
• Connectome-Based Prediction of Cocaine Abstinence.1 passage
• Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.1 passage
• Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study.1 passage
• Contraception for Women With Psychiatric Disorders.1 passage
• Contribution of Intellectual Disability-Related Genes to ADHD Risk and to Locomotor Activity in1 passage
• Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis.1 passage
• Correlates of Future Violence in People Being Treated for Schizophrenia.1 passage
• Cortical Abnormalities Associated With Pediatric and Adult Obsessive-Compulsive Disorder: Findings From the ENIGMA Obsessive-Compulsive Disorder Working Group.1 passage
• Cortical Functional Connectivity Evident After Birth and Behavioral Inhibition at Age 2.1 passage
• Cortical Thinning and Neuropsychiatric Outcomes in Children Exposed to Prenatal Adversity: A Role for Placental CRH?1 passage
• Cortical and Subcortical Brain Morphometry Differences Between Patients With Autism Spectrum Disorder and Healthy Individuals Across the Lifespan: Results From the ENIGMA ASD Working Group.1 passage
• Cortical morphology in 6- to 10-year old children with autistic traits: a population-based neuroimaging study.1 passage
• Cortico-Limbic Interactions Mediate Adaptive and Maladaptive Responses Relevant to Psychopathology.1 passage
• Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.1 passage
• Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.1 passage
• Defense Mechanisms of Pregnant Mothers Predict Attachment Security, Social-Emotional Competence, and Behavior Problems in Their Toddlers.1 passage
• Deficiency of Inflammatory Response to Acute Trauma Exposure as a Neuroimmune Mechanism Driving the Development of Chronic PTSD: Another Paradigmatic Shift for the Conceptualization of Stress-Related Disorders?1 passage
• Defining the Neural Substrate of the Adult Outcome of Childhood ADHD: A Multimodal Neuroimaging Study of Response Inhibition.1 passage
• Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.1 passage
• Depression and Insulin Resistance: Additional Support for the Novel Heuristic Model in Perimenopausal Depression.1 passage
• Depression-Related Increases and Decreases in Appetite: Dissociable Patterns of Aberrant Activity in Reward and Interoceptive Neurocircuitry.1 passage
• Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length.1 passage
• Detection of circulating miRNA levels in schizophrenia.1 passage
• Development and Validation of a Dementia Risk Prediction Model in the General Population: An Analysis of Three Longitudinal Studies.1 passage
• Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories.1 passage
• Developmental Trajectories of the Orbitofrontal Cortex and Anhedonia in Middle Childhood and Risk for Substance Use in Adolescence in a Longitudinal Sample of Depressed and Healthy Preschoolers.1 passage
• Developmental change in amygdala reactivity during adolescence: effects of family history of depression and stressful life events.1 passage
• Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.1 passage
• Diagnostic Classification for Human Autism and Obsessive-Compulsive Disorder Based on Machine Learning From a Primate Genetic Model.1 passage
• Diagnostic Precursors to Bipolar Disorder in Offspring of Parents With Bipolar Disorder: A Longitudinal Study.1 passage
• Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.1 passage
• Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology.1 passage
• Differential Response to Risperidone in Schizophrenia Patients by KCNH2 Genotype and Drug Metabolizer Status.1 passage
• Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications.1 passage
• Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies.1 passage
• Disrupted Dorsal Mid-Insula Activation During Interoception Across Psychiatric Disorders.1 passage
• Disruptive Behavior Disorders: The Challenge of Delineating Mechanisms in the Face of Heterogeneity.1 passage
• Dissociation in Psychiatric Disorders: A Meta-Analysis of Studies Using the Dissociative Experiences Scale.1 passage
• Distinct Patterns of Neural Habituation and Generalization in Children and Adolescents With Autism With Low and High Sensory Overresponsivity.1 passage
• Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development.1 passage
• Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis.1 passage
• Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation.1 passage
• Distinguishing Adolescents With ADHD From Their Unaffected Siblings and Healthy Comparison Subjects by Neural Activation Patterns During Response Inhibition.1 passage
• Distress During Pregnancy: Epigenetic Regulation of Placenta Glucocorticoid-Related Genes and Fetal Neurobehavior.1 passage
• Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.1 passage
• Divorce and the Onset of Alcohol Use Disorder: A Swedish Population-Based Longitudinal Cohort and Co-Relative Study.1 passage
• Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.1 passage
• Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.1 passage
• Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder.1 passage
• Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.1 passage
• Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression.1 passage
• Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience.1 passage
• Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality.1 passage
• Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.1 passage
• Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.1 passage
• Early Intervention in Bipolar Disorder.1 passage
• Early Parenting Intervention Effects on Brain Responses to Maternal Cues Among High-Risk Children.1 passage
• Early Variations in White Matter Microstructure and Depression Outcome in Adolescents With Subthreshold Depression.1 passage
• Effect Sizes of Deletions and Duplications on Autism Risk Across the Genome.1 passage
• Effect of Attention Training on Attention Bias Variability and PTSD Symptoms: Randomized Controlled Trials in Israeli and U.S. Combat Veterans.1 passage
• Effect of CBT on Biased Semantic Network in Panic Disorder: A Multicenter fMRI Study Using Semantic Priming.1 passage
• Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study.1 passage
• Effect of Hippocampal and Amygdala Connectivity on the Relationship Between Preschool Poverty and School-Age Depression.1 passage
• Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.1 passage
• Effect of Marriage on Risk for Onset of Alcohol Use Disorder: A Longitudinal and Co-Relative Analysis in a Swedish National Sample.1 passage
• Effect of the Affordable Care Act's young adult insurance expansions on hospital-based mental health care.1 passage
• Effectiveness of Early Psychosis Intervention: Comparison of Service Users and Nonusers in Population-Based Health Administrative Data.1 passage
• Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.1 passage
• Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data.1 passage
• Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.1 passage
• Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.1 passage
• Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.1 passage
• Effects of cognitive bias modification training on neural alcohol cue reactivity in alcohol dependence.1 passage
• Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.1 passage
• Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.1 passage
• Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial.1 passage
• Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.1 passage
• Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.1 passage
• Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.1 passage
• Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.1 passage
• Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial.1 passage
• Efficacy of Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Refractory Obsessive-Compulsive Disorder: A Clinical Cohort of 70 Patients.1 passage
• Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.1 passage
• Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial.1 passage
• Electroconvulsive Therapy in Mania: A Review of 80 Years of Clinical Experience.1 passage
• Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study.1 passage
• Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.1 passage
• Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank.1 passage
• Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study.1 passage
• Epigenetic Aging in Major Depressive Disorder.1 passage
• Evidence for Dissociable Linkage of Dimensions of Psychopathology to Brain Structure in Youths.1 passage
• Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.1 passage
• Evidence for Network-Based Cortical Thickness Reductions in Schizophrenia.1 passage
• Evolution, Emotion, and Episodic Engagement.1 passage
• Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.1 passage
• Exercise and the Prevention of Depression: Results of the HUNT Cohort Study.1 passage
• Exposure to Maternal Depressive Symptoms in Fetal Life or Childhood and Offspring Brain Development: A Population-Based Imaging Study.1 passage
• Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.1 passage
• Familiality of Psychiatric Disorders and Risk of Postpartum Psychiatric Episodes: A Population-Based Cohort Study.1 passage
• Feedback-driven trial-by-trial learning in autism spectrum disorders.1 passage
• Fetal Origins of Mental Health: The Developmental Origins of Health and Disease Hypothesis.1 passage
• Finding the Elusive Psychiatric "Lesion" With 21st-Century Neuroanatomy: A Note of Caution.1 passage
• Five-Year Suicidal Ideation Trajectories Among Women Receiving or Being Denied an Abortion.1 passage
• Fluidity of the Subsyndromal Phenomenology of Borderline Personality Disorder Over 16 Years of Prospective Follow-Up.1 passage
• From Rare Copy Number Variants to Biological Processes in ADHD.1 passage
• From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States.1 passage
• Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.1 passage
• Functional Connectome Prediction of Anxiety Related to the COVID-19 Pandemic.1 passage
• Functional Neuroimaging Predictors of Self-Reported Psychotic Symptoms in Adolescents.1 passage
• Functional neuroimaging of avoidance habits in obsessive-compulsive disorder.1 passage
• GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.1 passage
• GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.1 passage
• Gating Deficit Heritability and Correlation With Increased Clinical Severity in Schizophrenia Patients With Positive Family History.1 passage
• Gaze-Contingent Music Reward Therapy for Social Anxiety Disorder: A Randomized Controlled Trial.1 passage
• Gender-Corrective Surgery Promoting Mental Health in Persons With Gender Dysphoria Not Supported by Data Presented in Article.1 passage
• Gene-Environment Interaction in Youth Depression: Replication of the 5-HTTLPR Moderation in a Diverse Setting.1 passage
• General Predictors and Moderators of Depression Remission: A VAST-D Report.1 passage
• Genetic Heterogeneity in Depressive Symptoms Following the Death of a Spouse: Polygenic Score Analysis of the U.S. Health and Retirement Study.1 passage
• Genetic Markers of ADHD-Related Variations in Intracranial Volume.1 passage
• Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP Study.1 passage
• Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.1 passage
• Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.1 passage
• Genome-Wide Association Study of Suicide Death and Polygenic Prediction of Clinical Antecedents.1 passage
• Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.1 passage
• Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder.1 passage
• Heritability of Perinatal Depression and Genetic Overlap With Nonperinatal Depression.1 passage
• Heritable and Nonheritable Pathways to Early Callous-Unemotional Behaviors.1 passage
• Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.1 passage
• Hormonal Treatments for Major Depressive Disorder: State of the Art.1 passage
• Hyperactivity and Reduced Activation of Anterior Hippocampus in Early Psychosis.1 passage
• Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users.1 passage
• Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.1 passage
• IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk.1 passage
• Identification of Common Neural Circuit Disruptions in Cognitive Control Across Psychiatric Disorders.1 passage
• Identification of Common Neural Circuit Disruptions in Emotional Processing Across Psychiatric Disorders.1 passage
• Identification of Developmental and Behavioral Markers Associated With Genetic Abnormalities in Autism Spectrum Disorder.1 passage
• Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.1 passage
• Identification of Two Heritable Cross-Disorder Endophenotypes for Tourette Syndrome.1 passage
• Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.1 passage
• Identifying Novel Types of Irritability Using a Developmental Genetic Approach.1 passage
• Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.1 passage
• Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [1 passage
• Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program.1 passage
• Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients.1 passage
• Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression.1 passage
• Impact of early intervention on psychopathology, crime, and well-being at age 25.1 passage
• Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.1 passage
• Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.1 passage
• Implementation of Advanced Methods for Reproductive Pharmacovigilance in Autism: A Meta-Analysis of the Effects of Prenatal Antidepressant Exposure.1 passage
• Improving Depression Outcome by Patient-Centered Medical Management.1 passage
• Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review.1 passage
• Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT.1 passage
• In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients.1 passage
• Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study.1 passage
• Incomes and Outcomes: Social Security Disability Benefits in First-Episode Psychosis.1 passage
• Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study.1 passage
• Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia.1 passage
• Increased Risk of Smoking in Female Adolescents Who Had Childhood ADHD.1 passage
• Increasing Male Preponderance in Suicide Coinciding With a Reduction by Half in Total Suicides in the Danish Population Should Raise Awareness of Male Depression.1 passage
• Individual Patterns of Abnormality in Resting-State Functional Connectivity Reveal Two Data-Driven PTSD Subgroups.1 passage
• Individual Treatment of Posttraumatic Stress Disorder Using Mantram Repetition: A Randomized Clinical Trial.1 passage
• Infections as a Risk Factor for and Prognostic Factor After Substance-Induced Psychoses.1 passage
• Inflammation: depression fans the flames and feasts on the heat.1 passage
• Intellectual Disability and Psychotic Disorders in Children: Association With Maternal Severe Mental Illness and Exposure to Obstetric Complications in a Whole-Population Cohort.1 passage
• Intergenerational Effects of Maternal Holocaust Exposure on1 passage
• Interindividual Differences in Cortical Thickness and Their Genomic Underpinnings in Autism Spectrum Disorder.1 passage
• Internet Gaming Disorder: Investigating the Clinical Relevance of a New Phenomenon.1 passage
• Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis.1 passage
• Interrogating the Genetic Determinants of Tourette's Syndrome and Other Tic Disorders Through Genome-Wide Association Studies.1 passage
• Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.1 passage
• Irritability in Youths: A Translational Model.1 passage
• Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.1 passage
• Is Exposure Necessary? A Randomized Clinical Trial of Interpersonal Psychotherapy for PTSD.1 passage
• Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts.1 passage
• Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia.1 passage
• KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.1 passage
• Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.1 passage
• Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.1 passage
• Large-Scale Functional Brain Network Architecture Changes Associated With Trauma-Related Dissociation.1 passage
• Late-Onset ADHD Reconsidered With Comprehensive Repeated Assessments Between Ages 10 and 25.1 passage
• Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia.1 passage
• Learning About Safety: Conditioned Inhibition as a Novel Approach to Fear Reduction Targeting the Developing Brain.1 passage
• Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind.1 passage
• Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes.1 passage
• Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.1 passage
• Long-Term Effects of Evidence-Based Supported Employment on Earnings and on SSI and SSDI Participation Among Individuals With Psychiatric Disabilities.1 passage
• Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression.1 passage
• Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults.1 passage
• Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.1 passage
• Longitudinal Stability of Genetic and Environmental Influences on Irritability: From Childhood to Young Adulthood.1 passage
• Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.1 passage
• Low-Intensity Transcranial Current Stimulation in Psychiatry.1 passage
• Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.1 passage
• Lyme Borreliosis and Associations With Mental Disorders and Suicidal Behavior: A Nationwide Danish Cohort Study.1 passage
• Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.1 passage
• Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.1 passage
• Maternal Bacterial Infection During Pregnancy and Offspring Risk of Psychotic Disorders: Variation by Severity of Infection and Offspring Sex.1 passage
• Maternal Immune Activation and Neuropsychiatric Illness: A Translational Research Perspective.1 passage
• Maternal Psychological Resilience During Pregnancy and Newborn Telomere Length: A Prospective Study.1 passage
• Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters.1 passage
• Mechanisms of Diminished Attention to Eyes in Autism.1 passage
• Medial Prefrontal Aberrations in Major Depressive Disorder Revealed by Cytoarchitectonically Informed Voxel-Based Morphometry.1 passage
• Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.1 passage
• Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.1 passage
• Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.1 passage
• Mental Health Service Use and Psychopharmacological Treatment Following Psychotic Experiences in Preadolescence.1 passage
• Mental Health and Social Networks After Disaster.1 passage
• Messages for Clinicians: Moderators and Mediators of Treatment Outcome in Randomized Clinical Trials.1 passage
• Meta-Analysis of 89 Structural MRI Studies in Posttraumatic Stress Disorder and Comparison With Major Depressive Disorder.1 passage
• Meta-Analysis of fMRI Studies of Disruptive Behavior Disorders.1 passage
• Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.1 passage
• Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.1 passage
• Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.1 passage
• Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network.1 passage
• Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.1 passage
• Moderation of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study.1 passage
• Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis.1 passage
• Modification of Heritability for Educational Attainment and Fluid Intelligence by Socioeconomic Deprivation in the UK Biobank.1 passage
• Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression.1 passage
• Molecular Genetics and New Medication Strategies for Opioid Addiction.1 passage
• Molecular mechanisms and timing of cortical immune activation in schizophrenia.1 passage
• Mood Disorders and Outcomes of COVID-19 Hospitalizations.1 passage
• Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014.1 passage
• Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.1 passage
• Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.1 passage
• Mothers, Babies, Depression, and Medications: Understanding the Complex Interplay of Illness and Treatment on Neonatal Symptoms.1 passage
• Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.1 passage
• Multimodal Neuroimaging of Frontolimbic Structure and Function Associated With Suicide Attempts in Adolescents and Young Adults With Bipolar Disorder.1 passage
• Multimodal Neuroimaging of Suicidal Thoughts and Behaviors in a U.S. Population-Based Sample of School-Age Children.1 passage
• Multimodal Structural Neuroimaging Markers of Brain Development and ADHD Symptoms.1 passage
• Neonatal Brain Response to Deviant Auditory Stimuli and Relation to Maternal Trait Anxiety.1 passage
• Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders.1 passage
• Neural Correlates of Error Processing in Young People With a History of Severe Childhood Abuse: An fMRI Study.1 passage
• Neural Correlates of Irritability in Disruptive Mood Dysregulation and Bipolar Disorders.1 passage
• Neural Correlates of the Dual-Pathway Model for ADHD in Adolescents.1 passage
• Neural Correlates of the Propensity for Retaliatory Behavior in Youths With Disruptive Behavior Disorders.1 passage
• Neural Insensitivity to the Effects of Hunger in Women Remitted From Anorexia Nervosa.1 passage
• Neural Predictors of Initiating Alcohol Use During Adolescence.1 passage
• Neural Substrates of Overgeneralized Conditioned Fear in PTSD.1 passage
• Neurobiology of Self-Regulation: Longitudinal Influence of1 passage
• Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder.1 passage
• Neuroimaging Biomarkers in Schizophrenia.1 passage
• Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior.1 passage
• Neuromodulation Strategies for the Treatment of Depression.1 passage
• Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.1 passage
• Neuroscience of Addiction: Relevance to Prevention and Treatment.1 passage
• Nicotine Use and DSM-IV Nicotine Dependence in the United States, 2001-2002 and 2012-2013.1 passage
• No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis.1 passage
• No Association of Lower Hippocampal Volume With Alzheimer's Disease Pathology in Late-Life Depression.1 passage
• No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples.1 passage
• Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [1 passage
• Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.1 passage
• Norepinephrine Transporter in Major Depressive Disorder: A PET Study.1 passage
• Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.1 passage
• Offspring of Depressed Parents: 30 Years Later.1 passage
• Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.1 passage
• On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide.1 passage
• Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.1 passage
• Outcomes One and Two Winters Following Cognitive-Behavioral Therapy or Light Therapy for Seasonal Affective Disorder.1 passage
• Outcomes of Citalopram Dosage Risk Mitigation in a Veteran Population.1 passage
• Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis.1 passage
• Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.1 passage
• Overactive Performance Monitoring as an Endophenotype for Obsessive-Compulsive Disorder: Evidence From a Treatment Study.1 passage
• PTSD Psychotherapy Outcome Predicted by Brain Activation During Emotional Reactivity and Regulation.1 passage
• Pain as a Predictor of Opioid Use Disorder in a Nationally Representative Sample.1 passage
• Paraprofessional-delivered home-visiting intervention for American Indian teen mothers and children: 3-year outcomes from a randomized controlled trial.1 passage
• Parietal-Prefrontal Feedforward Connectivity in Association With Schizophrenia Genetic Risk and Delusions.1 passage
• Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.1 passage
• Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.1 passage
• Pediatric-Onset and Adult-Onset Separation Anxiety Disorder Across Countries in the World Mental Health Survey.1 passage
• Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems.1 passage
• Performance of DSM-5 Persistent Complex Bereavement Disorder Criteria in a Community Sample of Bereaved Military Family Members.1 passage
• Perinatal Maternal Depressive Symptoms as an Issue for Population Health.1 passage
• Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation.1 passage
• Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.1 passage
• Pervasively Thinner Neocortex as a Transdiagnostic Feature of General Psychopathology.1 passage
• Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism.1 passage
• Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.1 passage
• Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.1 passage
• Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.1 passage
• Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies.1 passage
• Pleiotropic locus for emotion recognition and amygdala volume identified using univariate and bivariate linkage.1 passage
• Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk.1 passage
• Polygenic Risk Score for Alzheimer's Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life.1 passage
• Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.1 passage
• Polygenic Risk: Predicting Depression Outcomes in Clinical and Epidemiological Cohorts of Youths.1 passage
• Post-Stroke Depression: A Review.1 passage
• Postpartum Psychosis: Madness, Mania, and Melancholia in Motherhood.1 passage
• Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes.1 passage
• Predicting Suicidal Behavior From Longitudinal Electronic Health Records.1 passage
• Predicting Suicide Attempts and Suicide Deaths Following Outpatient Visits Using Electronic Health Records.1 passage
• Prediction Error Representation in Individuals With Generalized Anxiety Disorder During Passive Avoidance.1 passage
• Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.1 passage
• Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.1 passage
• Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.1 passage
• Predictors of Suicide Attempt Within 30 Days After First Medically Documented Suicidal Ideation in U.S. Army Soldiers.1 passage
• Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings.1 passage
• Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data.1 passage
• Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.1 passage
• Prenatal Nicotine Exposure and Risk of Schizophrenia Among Offspring in a National Birth Cohort.1 passage
• Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy.1 passage
• Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.1 passage
• Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study.1 passage
• Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).1 passage
• Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.1 passage
• Prevalence and Correlates of Prescription Stimulant Use, Misuse, Use Disorders, and Motivations for Misuse Among Adults in the United States.1 passage
• Preventing Onset of Anxiety Disorders in Offspring of Anxious Parents: A Randomized Controlled Trial of a Family-Based Intervention.1 passage
• Prevention of Firearm Suicide in the United States: What Works and What Is Possible.1 passage
• Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients.1 passage
• Prospective longitudinal evaluation of the effect of deployment-acquired traumatic brain injury on posttraumatic stress and related disorders: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS).1 passage
• Protective Effects of Pregnancy on Risk of Alcohol Use Disorder.1 passage
• Psychedelics and Psychedelic-Assisted Psychotherapy.1 passage
• Psychiatric Genomics: An Update and an Agenda.1 passage
• Psychodynamic Therapy: As Efficacious as Other Empirically Supported Treatments? A Meta-Analysis Testing Equivalence of Outcomes.1 passage
• Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.1 passage
• Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program.1 passage
• Psychosocial Stress and Brain Function in Adolescent Psychopathology.1 passage
• Psychotherapy at a Distance.1 passage
• Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.1 passage
• Randomized Clinical Trial of Computerized and Clinician-Delivered CBT in Comparison With Standard Outpatient Treatment for Substance Use Disorders: Primary Within-Treatment and Follow-Up Outcomes.1 passage
• Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall.1 passage
• Randomized Controlled Trial Comparing Health Coach-Delivered Smartphone-Guided Self-Help With Standard Care for Adults With Binge Eating.1 passage
• Randomized Trial of Cognitive-Behavioral Therapy Versus Light Therapy for Seasonal Affective Disorder: Acute Outcomes.1 passage
• Randomized Trial of an Integrated Behavioral Health Home: The Health Outcomes Management and Evaluation (HOME) Study.1 passage
• Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.1 passage
• Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.1 passage
• Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.1 passage
• Reassessing Mental Health Treatment Utilization Reduction in Transgender Individuals After Gender-Affirming Surgeries: A Comment by the Editor on the Process.1 passage
• Reduced Structural Connectivity in Frontostriatal White Matter Tracts in the Associative Loop in Schizophrenia.1 passage
• Reducing Adolescent Psychopathology in Socioeconomically Disadvantaged Children With a Preschool Intervention: A Randomized Controlled Trial.1 passage
• Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial.1 passage
• Reduction in Mental Health Treatment Utilization Among Transgender Individuals After Gender-Affirming Surgeries: A Total Population Study.1 passage
• Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial.1 passage
• Reports to the Membership.2 passages
• Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran Program.1 passage
• Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.1 passage
• Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis.1 passage
• Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.1 passage
• Reward Processing in Children With Disruptive Behavior Disorders and Callous-Unemotional Traits in the ABCD Study.1 passage
• Reward Processing in Depression: A Conceptual and Meta-Analytic Review Across fMRI and EEG Studies.1 passage
• Reward-based spatial learning in unmedicated adults with obsessive-compulsive disorder.1 passage
• Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.1 passage
• Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine.1 passage
• Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis.1 passage
• Risk of Psychosis in Recurrent Episodes of Psychotic and Nonpsychotic Major Depressive Disorder: A Systematic Review and Meta-Analysis.1 passage
• Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.1 passage
• Role of Complex Epigenetic Switching in Tumor Necrosis Factor-α Upregulation in the Prefrontal Cortex of Suicide Subjects.1 passage
• Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.1 passage
• Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression.1 passage
• Selective Effects of Psychotherapy on Frontopolar Cortical Function in PTSD.1 passage
• Selective Loss of Smaller Spines in Schizophrenia.1 passage
• Sensation and Psychiatry: Linking Age-Related Hearing Loss to Late-Life Depression and Cognitive Decline.1 passage
• Sensitization of the Neural Salience Network to Repeated Emotional Stimuli Following Initial Habituation in Patients With Borderline Personality Disorder.1 passage
• Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.1 passage
• Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness.1 passage
• Service Use Preceding Opioid-Related Fatality.1 passage
• Shared or Distinct Alterations in Brain Structure in Disorders Across the Impulsivity-Compulsivity Spectrum: What Can We Learn From Cross-Disorder Comparisons of ADHD, ASD, and OCD?1 passage
• Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa.1 passage
• Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.1 passage
• Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.1 passage
• Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.1 passage
• Sleep Onset Problems and Subcortical Development in Infants Later Diagnosed With Autism Spectrum Disorder.1 passage
• Smartphone-Assisted Delivery of Cognitive-Behavioral Guided Self-Help for Binge Eating: Cautionary Musings of Implications Given the Importance of Comparison Groups.1 passage
• Smoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study.1 passage
• Social responsiveness, an autism endophenotype: genomewide significant linkage to two regions on chromosome 8.1 passage
• Stability of and Factors Related to Medical Student Specialty Choice of Psychiatry.1 passage
• Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.1 passage
• Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.1 passage
• State-Independent and Dependent Neural Responses to Psychosocial Stress in Current and Remitted Depression.1 passage
• Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups.1 passage
• Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.1 passage
• Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder.1 passage
• Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.1 passage
• Substance-Induced Psychotic Disorders and Schizophrenia: Pathophysiological Insights and Clinical Implications.1 passage
• Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.1 passage
• Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew.1 passage
• Suicide Following Deliberate Self-Harm.1 passage
• Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults.1 passage
• Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.1 passage
• Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.1 passage
• Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.1 passage
• Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.1 passage
• Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.1 passage
• Tele-Operating an Android Robot to Promote the Understanding of Facial Expressions and to Increase Facial Expressivity in Individuals With Autism Spectrum Disorder.1 passage
• Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.1 passage
• Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.1 passage
• The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.1 passage
• The Affordable Care Act's dependent coverage provision and young adults with psychiatric disorders.1 passage
• The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.1 passage
• The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders.1 passage
• The Brain's Response to Reward Anticipation and Depression in Adolescence: Dimensionality, Specificity, and Longitudinal Predictions in a Community-Based Sample.1 passage
• The Burden of Bereavement: Early-Onset Depression and Impairment in Youths Bereaved by Sudden Parental Death in a 7-Year Prospective Study.1 passage
• The Case for Cautious Interpretation and Replication: Lead-Time Bias as a Potential Explanation for the Link Between Duration of Untreated Psychosis and Outcome.1 passage
• The Clinical Effectiveness and Cost-Effectiveness of Lamotrigine in Borderline Personality Disorder: A Randomized Placebo-Controlled Trial.1 passage
• The Danish OPUS Early Intervention Services for First-Episode Psychosis: A Phase 4 Prospective Cohort Study With Comparison of Randomized Trial and Real-World Data.1 passage
• The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders.1 passage
• The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study.1 passage
• The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.1 passage
• The Emergent Course of Bipolar Disorder: Observations Over Two Decades From the Canadian High-Risk Offspring Cohort.1 passage
• The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia [SEPEA] Study.1 passage
• The Evolving Nexus of Sleep and Depression.1 passage
• The Genetic Epidemiology of Treated Major Depression in Sweden.1 passage
• The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study.1 passage
• The Impact of COVID-19 on Individuals With Intellectual and Developmental Disabilities: Clinical and Scientific Priorities.1 passage
• The Importance of Conduct Disorder in the Treatment of Violence in Schizophrenia: Efficacy of Clozapine Compared With Olanzapine and Haloperidol.1 passage
• The Intergenerational Transmission of Anxiety: A Children-of-Twins Study.1 passage
• The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.1 passage
• The Neurodevelopmental Basis of Early Childhood Disruptive Behavior: Irritable and Callous Phenotypes as Exemplars.1 passage
• The Origins of Cognitive Deficits in Victimized Children: Implications for Neuroscientists and Clinicians.1 passage
• The Overlapping Neurobiology of Induced and Pathological Anxiety: A Meta-Analysis of Functional Neural Activation.1 passage
• The Phenomenology of Major Depression and the Representativeness and Nature of DSM Criteria.1 passage
• The Protective Effect of Pregnancy on Risk for Drug Abuse: A Population, Co-Relative, Co-Spouse, and Within-Individual Analysis.1 passage
• The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank.1 passage
• The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium.1 passage
• The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study.1 passage
• The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.1 passage
• The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.1 passage
• The Role of Intrinsic Brain Functional Connectivity in Vulnerability and Resilience to Bipolar Disorder.1 passage
• The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.1 passage
• The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial.1 passage
• The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.1 passage
• The Sources of Parent-Child Transmission of Risk for Suicide Attempt and Deaths by Suicide in Swedish National Samples.1 passage
• The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?1 passage
• The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.1 passage
• The stone that mourns its victims: Haiti still recovering from its injuries and traumas 5 years after the 2010 earthquake.1 passage
• Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder.1 passage
• Thinking About Schizophrenia in an Era of Genomic Medicine.1 passage
• Thirty-Day Mortality After Infection Among Persons With Severe Mental Illness: A Population-Based Cohort Study in Denmark.1 passage
• Threat-Related Attention Bias Variability and Posttraumatic Stress.1 passage
• Time Course of Relapse Following Acute Treatment for Anorexia Nervosa.1 passage
• Toward Circuit Mechanisms of Pathophysiology in Depression.1 passage
• Toward Rigorous Methodologies for Strengthening Causal Inference in the Association Between Gender-Affirming Care and Transgender Individuals' Mental Health: Response to Letters.1 passage
• Toward the Definition of a Bipolar Prodrome: Dimensional Predictors of Bipolar Spectrum Disorders in At-Risk Youths.1 passage
• Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).1 passage
• Tracking Brain Development and Dimensional Psychiatric Symptoms in Children: A Longitudinal Population-Based Neuroimaging Study.1 passage
• Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.1 passage
• Transcriptome sequencing of the anterior cingulate in bipolar disorder: dysregulation of G protein-coupled receptors.1 passage
• Transformation of Mental Health Care for U.S. Soldiers and Families During the Iraq and Afghanistan Wars: Where Science and Politics Intersect.1 passage
• Transgender Research in the 21st Century: A Selective Critical Review From a Neurocognitive Perspective.1 passage
• Translating Across Circuits and Genetics Toward Progress in Fear- and Anxiety-Related Disorders.1 passage
• Translating Developmental Neuroscience to Understand Risk for Psychiatric Disorders.1 passage
• Treatment of maternal depression in a medication clinical trial and its effect on children.1 passage
• Treatment of psychosis and mania in the postpartum period.1 passage
• Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.1 passage
• Treatment-Specific Associations Between Brain Activation and Symptom Reduction in OCD Following CBT: A Randomized fMRI Trial.1 passage
• Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment.1 passage
• Trends in Outpatient Psychotherapy Provision by U.S. Psychiatrists: 1996-2016.1 passage
• Triparental families: a new genetic-epidemiological design applied to drug abuse, alcohol use disorders, and criminal behavior in a Swedish national sample.1 passage
• U.S. Adults With Pain, a Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001-2002 and 2012-2013.1 passage
• Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.1 passage
• Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial.1 passage
• Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies.1 passage
• Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework.1 passage
• Validation of electronic health record phenotyping of bipolar disorder cases and controls.1 passage
• Variable Emergence of Autism Spectrum Disorder Symptoms From Childhood to Early Adulthood.1 passage
• Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD.1 passage
• Ventral Striatum Functional Connectivity as a Predictor of Adolescent Depressive Disorder in a Longitudinal Community-Based Sample.1 passage
• Vulnerability for Alcohol Use Disorder and Rate of Alcohol Consumption.1 passage
• Well-Being, Burnout, and Depression Among North American Psychiatrists: The State of Our Profession.1 passage
• White Matter Abnormalities in Never-Treated Patients With Long-Term Schizophrenia.1 passage
• White Matter in Schizophrenia Treatment Resistance.1 passage
• Whither TMS: A One-Trick Pony or the Beginning of a Neuroscientific Revolution?1 passage
• Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition.1 passage
• Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results From a Randomized, Double-Blind, Placebo-Controlled Study.1 passage